ChartRow logo
ROIV
Roivant Sciences Ltd.Stock · Health Care
$36.29+$0.13 (+0.36%)as of market close, Aug 13, 2026
☾ After hours:$36.28+0.00%3:59 PM ET
CompareLLYUNHJNJABBVISRGTMO

ROIV financial statements

The full income statement, balance sheet, and cash-flow statement for Roivant Sciences Ltd. (ROIV), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 739.5M2024-09 727.9M2024-12 713.5M2025-03 679.8M2025-06 682.9M2025-09 695.5M2025-12 715.7M2026-03 719.3M2026-06 722.3M-2.3% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
Revenue
8.26M
YoY-71.6%
29.1M
YoY-11.2%
32.7M
YoY+3.8%
31.5M
YoY-43.0%
55.3M
YoY+132.3%
1.29B
YoY+13.2%
1.14B
YoY+29.3%
884M
YoY-5.8%
938M
YoY-33.3%
1.41B
YoY+28.5%
Operating income
-515M
YoY+48.7%
-1.00B
YoY-122.3%
4.50B
YoY+595.9%
-907M
YoY+32.9%
-1.35B
YoY-26.2%
Interest expense
34.8M
YoY+24.3%
28.0M
YoY+297.2%
7.04M
YoY+150.7%
Interest & investment income
178M
YoY-31.1%
258M
YoY+76.5%
146M
Other non-operating income
4.01M
YoY+137.4%
-10.7M
YoY+20.9%
-13.6M
YoY-2690.5%
-486K
YoY-115.0%
3.24M
YoY+137.2%
Equity-method income
0.00
YoY+100.0%
Pre-tax income
-265M
YoY+61.2%
-682M
YoY-114.9%
4.57B
YoY+616.1%
-885M
YoY+4.2%
-924M
YoY-2.8%
Income tax
133M
YoY+176.8%
48.2M
YoY+124.0%
21.5M
YoY+426.8%
4.08M
YoY+1006.2%
369K
YoY-78.1%
-300M
YoY-74.3%
-172M
YoY-104.0%
4.35B
YoY+531.0%
-1.01B
YoY-19.4%
-845M
YoY-4.5%
-$0.54
YoY-125.0%
-$0.24
YoY-104.6%
$5.23
YoY+468.3%
-$1.42
YoY-12.7%
-$1.26
Balance Sheetas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
5.17B
YoY+3.3%
5.00B
YoY-25.7%
6.73B
YoY+274.3%
1.80B
YoY-16.2%
2.15B
YoY-1.9%
5.71B
YoY+5.0%
5.44B
YoY-24.7%
7.22B
YoY+202.2%
2.39B
YoY-7.6%
2.59B
YoY-0.2%
281M
YoY+88.2%
149M
YoY-44.0%
267M
YoY-2.1%
272M
YoY+47.8%
184M
YoY-15.8%
416M
YoY+66.7%
250M
YoY-67.7%
774M
YoY-1.0%
782M
YoY+49.3%
524M
YoY-0.8%
4.53B
YoY-3.4%
4.69B
YoY-21.5%
5.97B
YoY+415.5%
1.16B
YoY-30.1%
1.66B
YoY-7.8%
Cash Flowas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
-750M
YoY+10.6%
-839M
YoY-9.7%
-765M
YoY+9.3%
-843M
YoY-24.4%
-678M
YoY-22.7%
-682M
YoY+61.4%
-1.77B
YoY-133.9%
5.20B
YoY+11854.6%
-44.3M
YoY-114.6%
303M
YoY+1056.7%
134M
YoY+111.0%
-1.22B
YoY-390.9%
419M
YoY-16.0%
499M
YoY+62.8%
307M
YoY-32.8%
FX effect on cash
616K
YoY-90.2%
6.28M
0.00
Net change in cash
-1.29B
YoY+66.2%
-3.82B
YoY-178.7%
4.86B
YoY+1372.1%
-382M
YoY-464.6%
-67.6M
Interest paid
0.00
YoY-100.0%
5.96M
YoY-41.9%
10.3M
YoY+93.6%
5.30M
YoY-4.2%
5.54M
YoY+174.4%
Income taxes paid
48.4M
YoY-21.9%
61.9M
YoY+401.1%
12.4M
YoY+140.9%
5.13M
YoY+459.8%
916K
YoY-77.5%
Valuation Ratiosas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
Market cap
19.9B
YoY+190.5%
6.86B
YoY-19.2%
8.49B
YoY+50.1%
5.66B
YoY+63.5%
3.46B
YoY-45.7%
P/E
1.9×
P/S
2412.1×
YoY+921.7%
236.1×
YoY+6.9%
220.8×
YoY+23.0%
179.5×
YoY+186.6%
62.6×
YoY-76.6%
P/B
4.4×
YoY+200.7%
1.5×
YoY+4.9%
1.4×
YoY-71.5%
4.9×
YoY+134.0%
2.1×
YoY-41.1%
52.6%
Source filing10-K10-K10-K10-K10-K

About this data

Source: ROIV's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ROIV filings on SEC EDGAR → Not investment advice.